Keyphrases
Addition Effect
20%
Autologous Dendritic Cells
40%
Best Response
20%
Blood Samples
20%
Cancer Immunotherapy
20%
Clinical Benefit
20%
Clinical Effect
20%
Clinical Response
40%
Clinical Setting
20%
Computed Tomography
20%
Cyclophosphamide
100%
Dendritic Cell Vaccine
100%
Dendritic Cells
60%
ELISpot Assay
40%
Flow Cytometry
20%
Immune Monitoring
40%
Immune Parameters
20%
Immune Regulation
20%
Immune Response
40%
Immunological Effects
20%
In Cancer
20%
Intradermal Injection
20%
Metastatic Melanoma
20%
Patient Cohort
20%
Phase I Trial
20%
Progressive Disease
20%
Proliferation Assay
40%
Regulatory Mechanism
20%
Regulatory T Cells
20%
Stable Disease
20%
Therapeutic Potential
20%
Treg
80%
Tumor Regression
20%
Vaccination
20%
Without Chemotherapy
20%
Medicine and Dentistry
Cancer Immunotherapy
16%
Cyclophosphamide
100%
Dendritic Cell
83%
Dendritic Cell Vaccine
100%
Diseases
16%
Flow Cytometry
16%
Immune Response
33%
Immunity
50%
Immunocompetent Cell
16%
Intradermal Drug Administration
16%
Melanoma
100%
Messenger RNA
100%
Phase I Trials
16%
Progressive Disease
16%
Regulatory T Cell
16%
Tumor Regression
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
16%
Cyclophosphamide
100%
Dendritic Cell Vaccine
100%
Diseases
33%
Flow Cytometry
16%
Immunotherapy
16%
Malignant Neoplasm
16%
Melanoma
100%
Messenger RNA
100%
Phase I Trials
16%
Tumor Regression
16%
Immunology and Microbiology
Cancer Immunotherapy
16%
Cyclophosphamide
100%
Dendritic Cell
83%
Dendritic Cell Vaccine
100%
Immune Response
33%
Immunity
50%
Immunocompetent Cell
16%
Regulatory T Cell
83%
X-Ray Computed Tomography
16%